Ruhina Maeshima
London, ENG WC1N1EH, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Ultrasound-guided renal artery administration of angiopoietin-1 RNA therapy slows the progression of preclinical WT1 glomerular disease.
Journal: Science translational medicine
Published: August 12, 2026
Low Molecular Weight Alginate Oligosaccharides as Alternatives to PEG for Enhancement of the Diffusion of Cationic Nanoparticles Through Cystic Fibrosis Mucus.
Journal: Advanced healthcare materials
Published: February 08, 2024
Lipid Nanoparticles Efficiently Deliver the Base Editor ABE8e for COL7A1 Correction in Dystrophic Epidermolysis Bullosa Fibroblasts In Vitro.
Journal: The Journal of investigative dermatology
Published: December 08, 2023
RNA Therapy for Oncogenic NRAS-Driven Nevi Induces Apoptosis.
Journal: The Journal of investigative dermatology
Published: November 10, 2023
Topical gene editing therapeutics using lipid nanoparticles: 'gene creams' for genetic skin diseases?
Journal: The British journal of dermatology
Published: November 03, 2023
BMI1 Transduction of Human Airway Epithelial Cells for Expansion of Proliferation and Differentiation.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 19, 2023
In vitro platform to model the function of ionocytes in the human airway epithelium.
Journal: Respiratory research
Published: September 03, 2023
Molecular and functional correction of a deep intronic splicing mutation in CFTR by CRISPR-Cas9 gene editing.
Journal: Molecular therapy. Methods & clinical development
Published: July 29, 2022
Lipid-peptide nanocomplexes for mRNA delivery in vitro and in vivo.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 08, 2022
Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved Survival.
Journal: Advanced functional materials
Published: May 21, 2021
MYCN Silencing by RNAi Induces Neurogenesis and Suppresses Proliferation in Models of Neuroblastoma with Resistance to Retinoic Acid.
Journal: Nucleic acid therapeutics
Published: April 03, 2020
The liposomal delivery of hydrophobic oxidovanadium complexes imparts highly effective cytotoxicity and differentiating capacity in neuroblastoma tumour cells.
Journal: Scientific reports
Published: March 12, 2020
Last Updated: 09/26/2026